Crewe Advisors LLC Adaptive Biotechnologies Corp Transaction History
Crewe Advisors LLC
- $709 Million
- Q4 2024
A detailed history of Crewe Advisors LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Crewe Advisors LLC holds 11,543 shares of ADPT stock, worth $89,458. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,543
Previous 11,543
-0.0%
Holding current value
$89,458
Previous $59,000
16.95%
% of portfolio
0.01%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding ADPT
# of Institutions
202Shares Held
144MCall Options Held
68.8KPut Options Held
42.5K-
Viking Global Investors LP30MShares$232 Million0.59% of portfolio
-
Rubric Capital Management LP New York, NY14.4MShares$112 Million2.05% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$90.4 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.6MShares$89.9 Million0.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.6MShares$82.5 Million0.0% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $1.11B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...